Rating History for Amylin Pharmaceuticals (AMLN) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for AMLN
Date Type Rating
(Past)		 PT
(Past)		 Start $ End $ % Chg. Details
1/30/2012 Maintain Sell
(N/A)		 11.00
(N/A)		       Details
10/13/2011 Maintain Sell
(N/A)		 8.00
(N/A)		       Details
2/8/2011 New Coverage Sell
(N/A)		 N/A
(N/A)		 16.07 30.98 92.78% Details